Log in | Register
Ozgur Mete MD, Lorne Rotstein MD, Sylvia L. Asa MD, PhD Endocrine Tumors Volume 17, Issue 2 / February , 2009
View full article HTML | View full article PDF | Download Citation
Endocrine pathologists, surgeons, and oncologists who manage patients with thyroid carcinomas confront many critical dilemmas. Controversies surrounding diagnostic criteria that distinguish benign from malignant thyroid follicular lesions have been brought to the attention of this community. In this article, we confront another controversy, the definition of a thyroid “capsule” to clarify what constitutes extrathyroidal extension (ETE) and its clinical significance in the management of patients with differentiated thyroid carcinomas.
Our review of the anatomy of the thyroid gland confirms that this structure has no defined anatomical fibrous capsule. Moreover, the presence of adipose tissue within the thyroid gland and its pseudocapsule implies that thyroid tumor within fat tissue cannot be accepted as a criterion of ETE by that thyroid carcinoma. While invasion of skeletal muscle is a more reliable feature of ETE, at the isthmus, these fibers can be normally present within the gland, and this criterion does not have value. This implies that anatomical localization is a critical element in the determination of ETE. Clarification of such issues should be reflected in future revisions of the UICC/AJCC staging criteria to allow more rational management of patients with these increasingly common cancers.
Go to Issue Contents
Add this article to your Personal Archive
New for 2010: Manuscripts submitted and/or accepted after January 1, 2010 must adhere to a 3,000 word limit (not including the title page, abstract, and references) and cannot contain more than 6 figures and tables combined. A figure that has multiple pieces counts as one figure (ie, Figure 1a and 1b counts as one figure).
For further information, reference the journal's Instructions for Authors